However, genetically engineered mice exhibiting low to no IL-10 signaling in the intestinal tract develop severe IBD manifestations [76]–[78], supporting a pivotal role of IL-10 in down-regulation of inflammation. Here, IL10 is linked to inflammatory bowel disease.